$2.70Billion | No. of Holdings #83
BRAIDWELL LP Performance
| Ticker | $ Bought |
|---|---|
| humana inc | 45,481,700 |
| maze therapeutics inc | 34,018,800 |
| avalo therapeutics inc | 30,107,300 |
| alamar biosciences inc | 29,365,100 |
| oruka therapeutics inc | 26,472,900 |
| avalyn pharmaceuticals inc | 26,381,900 |
| immunocore hldgs plc | 16,552,100 |
| ovid therapeutics inc | 15,923,400 |
| Ticker | % Inc. |
|---|---|
| repligen corp | 272 |
| alphatec hldgs inc | 200 |
| nektar therapeutics | 112 |
| transmedics group inc | 85.1 |
| climb bio inc | 82.87 |
| damora therapeutics inc | 81.08 |
| acadia healthcare company in | 76.73 |
| boston scientific corp | 69.59 |
| Ticker | % Reduced |
|---|---|
| repligen corp | -84.16 |
| neogenomics inc | -82.06 |
| argenx se | -79.15 |
| guardant health inc | -70.41 |
| celldex therapeutics inc new | -67.8 |
| mbx biosciences inc | -52.37 |
| neurocrine biosciences inc | -48.45 |
| dyne therapeutics inc | -45.21 |
| Ticker | $ Sold |
|---|---|
| guardant health inc | -102,576,000 |
| zenas biopharma inc | -13,455,000 |
| fulcrum therapeutics inc | -24,044,900 |
| engene holdings inc | -16,731,300 |
| arrowhead pharmaceuticals in | -2,333,480 |
| centessa pharmaceuticals plc | -78,914,400 |
| compass therapeutics inc | -10,395,400 |
| cg oncology inc | -66,650,100 |
BRAIDWELL LP has about 69.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 69.7 |
| Others | 30.3 |
BRAIDWELL LP has about 12.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 33 |
| UNALLOCATED | 30.3 |
| SMALL-CAP | 20.8 |
| LARGE-CAP | 11.1 |
| MICRO-CAP | 3 |
| MEGA-CAP | 1.7 |
About 46.1% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53.9 |
| RUSSELL 2000 | 38.9 |
| S&P 500 | 7.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
BRAIDWELL LP has 83 stocks in it's portfolio. About 31.3% of the portfolio is in top 10 stocks. TMDX proved to be the most loss making stock for the portfolio. was the most profitable stock for BRAIDWELL LP last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc BRAIDWELL LP's holding in Acadia Pharmaceuticals Inc over time | 1.54% | 1,646,400 | $41.65M 1.54% | 33.38%decreased 33.38 percentreduced | |
Acadia Healthcare Company In BRAIDWELL LP's holding in Acadia Healthcare Company In over time | 1.25% | 1,141,480 | $33.71M 1.25% | 76.73%increased 76.73 percentadded | |
Aclaris Therapeutics Inc BRAIDWELL LP's holding in Aclaris Therapeutics Inc over time | 0.42% | 2,142,350 | $11.33M 0.42% | 26.09%increased 26.09 percentadded | |
Spyre Therapeutics Inc BRAIDWELL LP's holding in Spyre Therapeutics Inc over time | 2.89% | 879,467 | $78.08M 2.89% | 5.72%decreased 5.72 percentreduced | |
Elevance Health Inc Formerly BRAIDWELL LP's holding in Elevance Health Inc Formerly over time | 0.77% | 53,960 | $20.87M 0.77% | 13.08%decreased 13.08 percentreduced | |
ARGX Argenx SeArgenx SeARGX | 0.61% | 17,707 | $16.43M 0.61% | 79.15%decreased 79.15 percentreduced | |
Arrowhead Pharmaceuticals In BRAIDWELL LP's holding in Arrowhead Pharmaceuticals In over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Alphatec Hldgs Inc BRAIDWELL LP's holding in Alphatec Hldgs Inc over time | 2.45% | 69,121,000 | $66.18M 2.45% | 12.17%increased 12.17 percentadded | |
Alphatec Hldgs Inc BRAIDWELL LP's holding in Alphatec Hldgs Inc over time | 2.09% | 6,531,440 | $56.50M 2.09% | 200.61%increased 200.61 percentadded | |
Aveanna Healthcare Hldgs Inc BRAIDWELL LP's holding in Aveanna Healthcare Hldgs Inc over time | 0.97% | 3,065,110 | $26.27M 0.97% | 39.1%increased 39.1 percentadded | |
Avalo Therapeutics Inc BRAIDWELL LP's holding in Avalo Therapeutics Inc over time | 1.11% | 1,629,180 | $30.11M 1.11% | Newnew position | |
Biomarin Pharmaceutical Inc BRAIDWELL LP's holding in Biomarin Pharmaceutical Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Boston Scientific Corp BRAIDWELL LP's holding in Boston Scientific Corp over time | 0.93% | 587,567 | $25.08M 0.93% | 69.59%increased 69.59 percentadded | |
Caredx Inc Caredx IncCDNA BRAIDWELL LP's holding in Caredx Inc over time | 1.29% | 1,220,600 | $34.79M 1.29% | 43.83%decreased 43.83 percentreduced | |
Celcuity Inc Celcuity IncCELC BRAIDWELL LP's holding in Celcuity Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Celldex Therapeutics Inc New BRAIDWELL LP's holding in Celldex Therapeutics Inc New over time | 0.6% | 436,646 | $16.25M 0.6% | 67.8%decreased 67.8 percentreduced | |
Compass Therapeutics Inc BRAIDWELL LP's holding in Compass Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Centene Corp Del BRAIDWELL LP's holding in Centene Corp Del over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Centessa Pharmaceuticals Plc BRAIDWELL LP's holding in Centessa Pharmaceuticals Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Corvus Pharmaceuticals Inc BRAIDWELL LP's holding in Corvus Pharmaceuticals Inc over time | 1.18% | 2,126,300 | $31.77M 1.18% | 21.31%increased 21.31 percentadded | |